Author： Ozaki Yoshio
Publisher： Springer Publishing Company
ISSN： 1439-7595
Source： Modern Rheumatology, Vol.21, Iss.3, 2011-06, pp. : 302-304
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
We report a 60-year-old woman with rheumatoid arthritis complicated by pericarditis. Treatment with tocilizumab improved her polyarthritis, but the pericardial effusion increased so rapidly as to cause cardiac tamponade before the treatment could prove its efficacy. Pericardial effusion disappeared after pericardiocentesis. The pericardial fluid contained a remarkably high concentration of interleukin-6 (IL-6; 351,000 pg/mL), which tocilizumab appeared to have made yet higher compared to the reported IL-6 levels in rheumatoid pericarditis. No further exacerbation of pericarditis was observed after retreatment with tocilizumab. This case has important implications in that it suggests that the prominently elevated IL-6 level in pericardial fluid during tocilizumab treatment may be an indicator of its efficacy for pericarditis.
Related content
Current Rheumatology Reviews, Vol. 7, Iss. 4, 2011-11 ,pp. :
Access to resources
Recommend
By Hishitani Y Ogata A Shima Y Hirano T Ebina K Kunugiza Y Shi K Narazaki M Hagihara K Tomita T Yoshikawa H Tanaka T Kumanogoh A
Scandinavian Journal of Rheumatology, Vol. 42, Iss. 4, 2013-08 ,pp. :
By Kato Takashi Koni Ichiro Inoue Ryo Kitajima Susumu Kawano Mitsuhiro Yamagishi Masakazu
Modern Rheumatology, Vol. 20, Iss. 3, 2010-06 ,pp. :
High Titer of Anticardiolipin Antibody Is Associated with First-Ever Ischemic Stroke in Taiwan
Cerebrovascular Diseases, Vol. 22, Iss. 4, 2006-08 ,pp. :